After beating the street’s estimates in Q1 17, UPM-Kymmene’s Q2 17 performance fell short of expectations – especially in profitability terms. Sales (again) were almost flat (+0.8% yoy; -0.7% qoq) at €2.5bn, as gains in Biorefining (+12% yoy, +3.8% qoq; driven by price improvements), Speciality Papers (+4.6% yoy, +3.6% qoq; yoy helped by a better product mix and qoq by volumes), Raflatac (+4.2% yoy, +1.1% qoq; benefiting from higher volumes) and Plywood (+7.6% yoy, +3.2
04 Oct 2017
Despite a weak Q2, inherent strengths remain intact
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Despite a weak Q2, inherent strengths remain intact
After beating the street’s estimates in Q1 17, UPM-Kymmene’s Q2 17 performance fell short of expectations – especially in profitability terms. Sales (again) were almost flat (+0.8% yoy; -0.7% qoq) at €2.5bn, as gains in Biorefining (+12% yoy, +3.8% qoq; driven by price improvements), Speciality Papers (+4.6% yoy, +3.6% qoq; yoy helped by a better product mix and qoq by volumes), Raflatac (+4.2% yoy, +1.1% qoq; benefiting from higher volumes) and Plywood (+7.6% yoy, +3.2